| pubmed-article:19647907 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19647907 | lifeskim:mentions | umls-concept:C0022237 | lld:lifeskim |
| pubmed-article:19647907 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
| pubmed-article:19647907 | lifeskim:mentions | umls-concept:C0220781 | lld:lifeskim |
| pubmed-article:19647907 | lifeskim:mentions | umls-concept:C1883254 | lld:lifeskim |
| pubmed-article:19647907 | lifeskim:mentions | umls-concept:C0243071 | lld:lifeskim |
| pubmed-article:19647907 | lifeskim:mentions | umls-concept:C0599473 | lld:lifeskim |
| pubmed-article:19647907 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:19647907 | pubmed:dateCreated | 2009-11-25 | lld:pubmed |
| pubmed-article:19647907 | pubmed:abstractText | The synthesis of (2RS)-1-(5-methoxy-1H-indol-4-yloxy)-3-(2-(2-methoxyphenoxy)ethylamino)propan-2-ol and (2RS)-1-(7-methoxy-1H-indol-4-yloxy)-3-(2-(2-methoxyphenoxy)ethylamino)propan-2-ol and its enantiomers, analogs of 1-(1H-indol-4-yloxy)-3-(2-(2-methoxyphenoxy)ethylamino)propan-2-ol ((RS)-9) is described. Compounds were tested for electrographic, antiarrhythmic, hypotensive and spasmolytic activities as well as for alpha(1)-, alpha(2)- and beta(1)-adrenoceptors binding affinities. The antagonist potency of the new compounds was compared with carvedilol and (RS)-9. | lld:pubmed |
| pubmed-article:19647907 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19647907 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19647907 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19647907 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19647907 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19647907 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19647907 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19647907 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19647907 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19647907 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19647907 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:19647907 | pubmed:issn | 1768-3254 | lld:pubmed |
| pubmed-article:19647907 | pubmed:author | pubmed-author:FilipekBarbar... | lld:pubmed |
| pubmed-article:19647907 | pubmed:author | pubmed-author:BednarskiMare... | lld:pubmed |
| pubmed-article:19647907 | pubmed:author | pubmed-author:WalczakMariaM | lld:pubmed |
| pubmed-article:19647907 | pubmed:author | pubmed-author:GroszekGrazyn... | lld:pubmed |
| pubmed-article:19647907 | pubmed:author | pubmed-author:Nowak-KrólAgn... | lld:pubmed |
| pubmed-article:19647907 | pubmed:author | pubmed-author:WdowikTomaszT | lld:pubmed |
| pubmed-article:19647907 | pubmed:author | pubmed-author:Swierczy?skiD... | lld:pubmed |
| pubmed-article:19647907 | pubmed:author | pubmed-author:OttoMonikaM | lld:pubmed |
| pubmed-article:19647907 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19647907 | pubmed:volume | 44 | lld:pubmed |
| pubmed-article:19647907 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19647907 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19647907 | pubmed:pagination | 5103-11 | lld:pubmed |
| pubmed-article:19647907 | pubmed:meshHeading | pubmed-meshheading:19647907... | lld:pubmed |
| pubmed-article:19647907 | pubmed:meshHeading | pubmed-meshheading:19647907... | lld:pubmed |
| pubmed-article:19647907 | pubmed:meshHeading | pubmed-meshheading:19647907... | lld:pubmed |
| pubmed-article:19647907 | pubmed:meshHeading | pubmed-meshheading:19647907... | lld:pubmed |
| pubmed-article:19647907 | pubmed:meshHeading | pubmed-meshheading:19647907... | lld:pubmed |
| pubmed-article:19647907 | pubmed:meshHeading | pubmed-meshheading:19647907... | lld:pubmed |
| pubmed-article:19647907 | pubmed:meshHeading | pubmed-meshheading:19647907... | lld:pubmed |
| pubmed-article:19647907 | pubmed:meshHeading | pubmed-meshheading:19647907... | lld:pubmed |
| pubmed-article:19647907 | pubmed:meshHeading | pubmed-meshheading:19647907... | lld:pubmed |
| pubmed-article:19647907 | pubmed:meshHeading | pubmed-meshheading:19647907... | lld:pubmed |
| pubmed-article:19647907 | pubmed:meshHeading | pubmed-meshheading:19647907... | lld:pubmed |
| pubmed-article:19647907 | pubmed:meshHeading | pubmed-meshheading:19647907... | lld:pubmed |
| pubmed-article:19647907 | pubmed:meshHeading | pubmed-meshheading:19647907... | lld:pubmed |
| pubmed-article:19647907 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19647907 | pubmed:articleTitle | Synthesis and adrenolytic activity of 1-(1H-indol-4-yloxy)-3-(2-(2-methoxy phenoxy)ethylamino)propan-2-ol analogs and its enantiomers. Part 2. | lld:pubmed |
| pubmed-article:19647907 | pubmed:affiliation | Faculty of Chemistry, Rzeszów University of Technology, 6 Powsta?ców Warszawy Avenue, 35-959 Rzeszów, Poland. ggroszek@prz.edu.pl | lld:pubmed |
| pubmed-article:19647907 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:19647907 | lld:chembl |
